Parathyroid carcinoma with multiple brown tumors and pathological fracture: case report
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 María Zhindón Astudillo, Emilio Criollo Vargas, Luis Arteaga Ludeña, Erick Zambrano Franco

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
DOI:
https://doi.org/10.33821/780Keywords:
parathyroid carcinoma, brown tumors, pathological fracture, hyperparathyroidism, clinical caseAbstract
Introduction: Parathyroid carcinoma is a rare endocrine neoplasia that accounts for less than 1% of cases of primary hyperparathyroidism and usually presents with severe hypercalcemia and bone involvement. Clinical case: A 27-year-old male patient was referred for persistent pain in his right knee, exacerbated by minor trauma. Radiographic studies identified a pathological fracture and multiple osteolytic lesions. Biochemical analyses showed severe hypercalcemia (16.9 mg/dL), acute renal failure, and electrolyte disturbances. A bone biopsy reported a brown tumor, and a parathyroid scan revealed an ectopic mediastinal adenoma. The parathyroid adenoma was resected, and immunohistochemical analysis showed vascular permeation with a positive CD31 staining, confirming parathyroid carcinoma. The patient underwent complementary hemithyroidectomy, orthopedic treatment with tumor dissection, cementation, and internal fixation, along with zoledronic acid. The patient is currently being monitored without clinical or biochemical recurrence. Conclusion: This case highlights the importance of considering parathyroid carcinoma in young patients with severe hypercalcemia and multiple bone lesions. Immunohistochemistry is essential to confirm malignancy and determine surgical treatment. Comprehensive multidisciplinary management reduces complications, controls hypercalcemia, and improves prognosis.
Downloads
References
Lofrese JJ, Basit H, Lappin SL. Physiology, Parathyroid. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 [citado 2025 sep 12]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK482510/
Ullah A, Khan J, Waheed A, Sharma N, Pryor EK, Stumpe TR, et al. Parathyroid carcinoma: Incidence, survival analysis, and management: A study from the SEER database and insights into future therapeutic perspectives. Cancers (Basel). 2022;14(6). https://doi.org/10.3390/cancers14061426
Laforgia R, Tomasicchio G, Cavalera F, Sblendorio M, Spadone A, Anelli FM, et al. Management and surgical treatment of parathyroid carcinoma: A 6-year experience of a single centre of endocrine surgery unit. Front Endocrinol (Lausanne). 2023;14:1278178. https://doi.org/10.3389/fendo.2023.1278178
Ayadi S, Kharrat O, Ben Salah D, Hbaieb Y, Kallel S, Mnejja M, et al. Parathyroid carcinomas: A series of 6 cases and literature review. Ear Nose Throat J. 2024. https://doi.org/10.3389/fendo.2023.1278178
Roser P, Leca BM, Coelho C, Schulte KM, Gilbert J, Drakou EE, et al. Diagnosis and management of parathyroid carcinoma: A state-of-the-art review. Endocr Relat Cancer. 2023;30(4). https://doi.org/10.1530/ERC-22-0287
Alberti A, Smussi D, Zamparini M, Turla A, Laini L, Marchiselli C, et al. Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases. Front Oncol. 2022;12:997009. https://doi.org/10.3389/fonc.2022.997009
Erickson LA, Mete O, Juhlin CC, et al. Resumen de la Clasificación de Tumores Paratiroideos de la OMS 2022. Endocr Pathol 33, 64–89 (2022). https://doi.org/10.1007/s12022-022-09709-1
Martínez RW, Castaño RM, Rivera Martínez A, Ramírez Castaño MJ, Román González A. Actualización en el diagnóstico y tratamiento del carcinoma de paratiroides: revisión narrativa. Rev Colomb Endocrinol Diabetes Metab. 2025;12(1). https://doi.org/10.53853/encr.12.1.930
Grabill N, Louis M, Machado N, Brown P, Ellis E, So S. A case series on parathyroid carcinoma: Diagnostic challenges and therapeutic approaches. Int J Surg Case Rep. 2024;125:110601. https://doi.org/10.1016/j. ijscr.2024.110601
Viswanath A, Drakou EE, Lajeunesse-Trempe F, Grossman AB, Dimitriadis GK. Parathyroid carcinoma: New insights. Best Pract Res Clin Endocrinol Metab. 2025;39(2):101966. https://doi.org/10.1016/j.beem.2024.101966
PDQ Adult Treatment Editorial Board. Parathyroid Cancer Treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries [Internet]. 2002 [citado 2025 jun 25]; Disponible en: https://www. cancer.gov/types/parathyroid/hp/parathyroid-treatment-pdq
Cappellacci F, Medas F, Canu GL, Lai ML, Conzo G, Erdas E, et al. Parathyroid carcinoma in the setting of tertiary hyperparathyroidism: Case report and review of the literature. Case Rep Endocrinol. 2020;2020:5710468. https://doi.org/10.1155/2020/5710468
Marini F, Giusti F, Palmini G, Aurilia C, Donati S, Brandi ML. Parathyroid carcinoma: Update on pathogenesis and therapy. Endocrines. 2023;4(1):205-35. https://doi.org/10.3390/endocrines4010018
Hadoux J, Lamarca A, Grande E, Deandreis D, Kaltsas G, Janson ET, et al. Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. ESMO Open. 2024;9(10):103664. https://doi.org/10.1016/j.esmoop.2024.103664
Do Cao C, Christou N, Hadoux J, Deandreis D. Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor. Ann Endocrinol (Paris). 2025;86(1):101697. https://doi.org/10.1016/j.ando.2025.101697
Yu Z, Zhou J, Li F, Xie X, Hu L, Chen L, et al. Efficacy of surufatinib in the treatment of advanced parathyroid carcinoma: A case report. Heliyon. 2024;10(17): e36656. https://doi.org/10.1016/j.ando.2025.101697
Kubal M, Lech M, Lajeunesse-Trempe F, Drakou EE, Grossman AB, Dimitriadis GK. Advances in the management of parathyroid carcinoma. Mol Cell Endocrinol. 2024; 592:112329. https://doi.org/10.1016/j. mce.2024.112329
McInerney NJ, Moran T, O’Duffy F. Parathyroid carcinoma: Current management and outcomes: A systematic review. Am J Otolaryngol. 2023;44(4):103843. https://doi.org/10.1016/j.amjoto.2023.103843
